MedTrace Logo

Multimodal Imaging of ECT Effects

NCT02871141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2022-11-01

No results posted yet for this study

Summary

The project aims to investigate markers of neural activity and connectivity, neurochemistry, hypothalamic-pituitary-adrenal (HPA) axis activity, inflammation and neuronal plasticity underlying treatment response and remission after ECT. These measures will be assessed in depressive patients prior, during and after ECT and also after 6 months. Furthermore, we will investigate a control group of depressive patients treated with antidepressants.

Conditions

Interventions

PROCEDURE

electroconvulsive therapy

electroconvulsive therapy

DRUG

Antidepressant

Antidepressant

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Malek Bajbouj, MD · Charité

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2021-05-31
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02871141 on ClinicalTrials.gov